Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib
Proteinuria has been described as a major on-target adverse event of lenvatinib, although its long-term impact on renal function and clinical outcomes remains unclear. We conducted a retrospective observational study to assess renal function and prognosis in patients with radioiodine-refractory diff...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Japan Endocrine Society
2024-04-01
|
| シリーズ: | Endocrine Journal |
| 主題: | |
| オンライン･アクセス: | https://www.jstage.jst.go.jp/article/endocrj/71/4/71_EJ23-0378/_html/-char/en |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|